{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:40:15Z","timestamp":1791819615261,"version":"4.3.4"},"reference-count":129,"publisher":"The Korean Association for the Study of the Liver","issue":"4","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["e-cmh.org"],"crossmark-restriction":true},"short-container-title":["Clin Mol Hepatol"],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a spectrum of pathology involving fatty liver disease that may progress to fibrosis, cirrhosis, hepatocellular carcinoma, and liver failure. The prevalence of MASLD and metabolic dysfunction-associated steatohepatitis (MASH) continues to increase, mirroring the rise in global prevalence of related comorbidities such as obesity and type 2 diabetes mellitus. Due to the alarming rise of these comorbidities, a greater proportion of the population is at risk for developing MASLD and MASH. As such, there has been a significant effort to develop effective therapies for MASLD and MASH. Recently, the U.S. Food and Drug Administration approved resmetirom, a selective thyroid hormone receptor-beta agonist, as the first treatment for patients with MASH. In India, the Drug Controller General of India approved saroglitazar, a dual peroxisome proliferator-activated receptor (PPAR) \u03b1\/\u03b3 agonist, for the treatment of MASLD. Currently, we have various drug classes, including liver-specific therapies, in Phase 3 development with even more agents earlier in the pipeline. This review will discuss prospective therapies in later stages of development such as thyroid hormone receptor-beta agonists, PPAR agonists, glucagon-like peptide-1 receptor agonists, fibroblast growth factor 21 agonists, and fatty acid synthase inhibitors.<\/jats:p>","DOI":"10.3350\/cmh.2025.0337","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T06:53:13Z","timestamp":1754290393000},"page":"1167-1196","update-policy":"https:\/\/doi.org\/10.3350\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prospects of late-stage development agents in the treatment of metabolic dysfunction-associated steatohepatitis"],"prefix":"10.3350","volume":"31","author":[{"given":"Brian","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ussama","family":"Ghumman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1069-0490","authenticated-orcid":true,"given":"Lisa D.","family":"Pedicone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres Gomez","family":"Aldana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Lawitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1902","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000004"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.03.006"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14577"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29367"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.03.041"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000323"},{"key":"ref7","first-page":"1966","volume-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","author":"Rinella","year":"2023"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2023.100485"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0088-6"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2019.01.190"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0055-0"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000333210"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0316"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-08955-x"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(19)30383-8"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.036"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21178"},{"key":"ref18","first-page":"528","volume-title":"American association of clinical endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: co-sponsored by the American Association for the Study of Liver Diseases (AASLD)","author":"Cusi","year":"2022"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.04.031"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2024.0506"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-020-10094-2"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1080\/00365520802555991"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.07.013"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.04.015"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.3.603"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23276"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.02.023"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.005"},{"key":"ref29","volume-title":""},{"key":"ref30","volume-title":""},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.043"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.17925\/ee.2023.19.1.60"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1300"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200310000-00014"},{"key":"ref35","first-page":"497","volume-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","author":"Harrison","year":"2024"},{"key":"ref36","volume-title":""},{"key":"ref37","volume-title":""},{"key":"ref38","volume-title":""},{"key":"ref39","volume-title":""},{"key":"ref40","volume-title":""},{"key":"ref41","first-page":"13","volume-title":"Results from the 52-week phase 2b VOYAGE trial of VK2809 in patients with biopsy-confirmed non-alcoholic steatohepatitis and fibrosis: a randomized, placebo-controlled trial","author":"Alkhouri","year":"2024"},{"key":"ref42","volume-title":""},{"key":"ref43","volume-title":""},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.07.004"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113127"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-018-2838-4"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3390\/biom13081264"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19072124"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/549627"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25889"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2036205"},{"key":"ref52","volume-title":""},{"key":"ref53","volume-title":""},{"key":"ref54","first-page":"S326","volume-title":"A prospective, multi-center, double-blind, randomized trial of saroglitazar 4 mg versus placebo in patients with non-alcoholic steatohepatitis (EVIDENCES II)","author":"Sarin","year":"2020"},{"key":"ref55","volume-title":""},{"key":"ref56","volume-title":""},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31843"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.01.018"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-123364\/v1"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa0907929"},{"key":"ref61","volume-title":""},{"key":"ref62","volume-title":""},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-021-10242-2"},{"key":"ref64","volume-title":""},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.07.033"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2013.09.010"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2028395"},{"key":"ref68","volume-title":""},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2413258"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1111\/apt.18331"},{"key":"ref71","volume-title":""},{"key":"ref72","volume-title":""},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(23)00068-7"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2401755"},{"key":"ref75","volume-title":""},{"key":"ref76","volume-title":""},{"key":"ref77","volume-title":""},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2401943"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)01324-6"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2206038"},{"key":"ref81","first-page":"613","volume-title":"Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","author":"Garvey","year":"2023"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(23)00272-8"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1089214"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.00419"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.04.034"},{"key":"ref86","volume-title":""},{"key":"ref87","volume-title":""},{"key":"ref88","volume-title":""},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2502242"},{"key":"ref90","volume-title":""},{"key":"ref91","volume-title":""},{"key":"ref92","volume-title":""},{"key":"ref93","volume-title":""},{"key":"ref94","volume-title":""},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2304286"},{"key":"ref96","volume-title":""},{"key":"ref97","volume-title":""},{"key":"ref98","volume-title":""},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1093\/lifemeta\/loae029"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29735-6"},{"key":"ref101","volume-title":""},{"key":"ref102","volume-title":""},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(24)00246-2"},{"key":"ref104","volume-title":""},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.05.046"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.4291\/wjgp.v15.i2.92791"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1038\/ng.257"},{"key":"ref108","first-page":"2184","volume-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","author":"Younossi","year":"2019"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.01.038"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31205"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.07.027"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31622"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.04.003"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(23)00634-7"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000980"},{"key":"ref116","volume-title":""},{"key":"ref117","volume-title":""},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(25)00067-6"},{"key":"ref119","volume-title":""},{"key":"ref120","volume-title":""},{"key":"ref121","volume-title":""},{"key":"ref122","volume-title":""},{"key":"ref123","volume-title":""},{"key":"ref124","volume-title":""},{"key":"ref125","volume-title":""},{"key":"ref126","volume-title":""},{"key":"ref127","volume-title":""},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-083735"},{"key":"ref129","volume-title":""}],"container-title":["Clinical and Molecular Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/e-cmh.org\/upload\/pdf\/cmh-2025-0337.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-cmh.org\/journal\/view.php?doi=10.3350\/cmh.2025.0337","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-cmh.org\/upload\/pdf\/cmh-2025-0337.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T07:49:57Z","timestamp":1760600997000},"score":1,"resource":{"primary":{"URL":"http:\/\/e-cmh.org\/journal\/view.php?doi=10.3350\/cmh.2025.0337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":129,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"URL":"https:\/\/doi.org\/10.3350\/cmh.2025.0337","relation":{},"ISSN":["2287-2728","2287-285X"],"issn-type":[{"value":"2287-2728","type":"print"},{"value":"2287-285X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"2025-03-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-04","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-01","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}